Cardia Bioplastics Announces Collaboration with Nestle to Reduce Environmental Impact of Packaging

Dec 06, 2010, 03:00 ET from Cardia Bioplastics

MELBOURNE, Australia, Dec. 6, 2010 /PRNewswire/ -- Cardia Bioplastics announces its collaboration with Nestle S.A., the largest Fast Moving Consumer Goods company in the world, to reduce the environmental impact of packaging.

Cardia Bioplastics Managing Director Dr Frank Glatz said: "Collaborating with Nestle presents an exciting opportunity to develop high performance packaging with lower environmental impact. In addition to offering a product with beneficial environmental profile and full food safety compliance, delivering superior packaging performance through the product life cycle is a key criterion for success."

"Our proprietary multi-layer flexible film and rigid packaging developments are important offerings in meeting demanding packaging performance requirements," he said.

Cardia is well positioned to benefit from the trend towards sustainable packaging. It offers customers the choice of using sustainable Cardia Biohybrid(TM) technology (less oil, lower carbon foot print) or compostable technology (delivering certified compostability to international standards) for their packaging or plastic product solutions. The company's materials are suitable for a broad range of packaging applications, including flexible film, injection moulding, blow moulding, foam, and extrusion and coating applications.

About Cardia Bioplastics

Cardia Bioplastics Limited (ASX CODE: CNN), through its 100% owned subsidiary Cardia Bioplastics (Australia) Pty Ltd, develops, manufactures and markets its patented renewable resource based materials and finished products derived from Cardia's proprietary technology for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. Established in Australia in 2002 as Biograde, the company Headquarters and Global Applications Development Centre is in Melbourne, Australia. The Product Development Centre and manufacturing plant is in Nanjing, China. There are Cardia Bioplastics offices in the Americas, Europe, Malaysia and China, and a network of leading distributors across the Americas, Asia and Europe. Visit

www.cardiabioplastics.com

Further information:

Dr Frank Glatz


Managing Director


Cardia Bioplastics


+61 400 930 530




Barry Oosthuizen


Communication Advisor


Cardia Bioplastics


+61 413 185 135



SOURCE Cardia Bioplastics



RELATED LINKS

http://www.cardiabioplastics.com